Dr Reddy's to invest Rs.25 crore in AurigeneIllustrative image – not actual.

The board of Dr Reddy’s Laboratories has decided to invest another Rs.25 crore in the equity share capital of Aurigene Discovery Technologies, a wholly owned subsidiary of the company.

 

Aurigene has set up a research facility in Electronic City, Bangalore, with an initial investment of Rs.25 crore for post-genomic drug discovery activity.

 

Initially, Aurigene plans to focus on establishing alliances with pharmaceutical companies for chemistry and protein services and other related drug discovery activities. The company, which is in a start up phase now, plans to have around 100 scientists by the end of the first year of operations.

← All latest storiesBack to top →